Novel mathematical approach reveals shared gene programs in anti-tumor CD8+ T cells

FHS
July 3, 2024
3:22 am

We set out to identify genes that are commonly expressed in CD8+ T cells, killer immune cells that can drive anti-tumor immunity, across many types of human cancers.

The tiny pills that may send shockwaves across immunology

A significant shift within the psoriasis landscape and the larger immunology market is taking shape. In the coming months and years, industry attention will turn

June 6, 2024

Womb pressure shapes facial features, UCL study reveals

Physical cues in the womb, and not just genetics, influence the normal development of neural crest cells, the embryonic stem cells that form facial features,

April 23, 2024

Novartis expands Cosentyx reach for rheumatic diseases with IV version approval – Pharmaceutical Technology

The approval of Cosentyx as an IV formulation along with subcutaneous formulations broadens treatment options for patients. Credit: Pramote Polyamate via Getty Images. The US

October 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.